ting pang eng

  • Following

    5

  • Followers

    62


Fame: 1,634
No Bio yet.

Joined May 2017

Comments

The Glove Industry: A Roller Coaster We've All Ridden

I've been watching this sector for years, and what a ride it's been.

Phase 1: The Demand Shock (2020–2021)
COVID hit. Gloves became gold. ASPs skyrocketed, plant utilisation hit 100%, and every player was printing money. Hartalega's FY21 net profit hit RM2.4b, FY22 RM2.6b. Dividends hit 50–57 sen. Everyone thought it would last forever.

Phase 2: The Supply Flood (2022–2023)
It didn't. Everyone expanded. China's Intco and Bluesail ramped up aggressively, dumping supply into the market. ASPs collapsed. Hartalega swung to a RM218m net loss in FY23. Top Glove bled for two years. The red ocean was brutal — overcapacity, price wars, and margin destruction.

Phase 3: The Slow Grind Back (2024–2026)
The survivors didn't sit still. Malaysian players — Top Glove, Hartalega, Kossan — went into overdrive on manpower, process, plant, and equipment optimisation. Automation, workforce consolidation, cost-per-unit reduction. They couldn't control ASPs, so they controlled what they could.

Then came the tailwinds:

· Raw material shortages (NBR supply tightness)
· Geopolitical instability (Middle East tensions → oil spike → cost pass-through)
· Improved pricing discipline among Chinese makers
· Gradual demand recovery

Phase 4: Where Are We Now? (2026–2027)
The industry is normalising — but not to the astronomical profits of 2021. To something more... decent. Hartalega's FY27 forecasts show ~RM70m net profit. Top Glove's FY27F ranges from RM218m to RM525m depending on who you ask (yes, the analyst spread is that wide).

This is the new reality: a fragile oligopoly, not a gold rush.

The Key Insight:

This industry will kill everyone in a pure red ocean. But if it consolidates into a rational oligopoly — where the top players compete on cost, not price — everyone survives. Not with 50% margins, but with decent, sustainable profits.

And then you wait.

Because the next huge demand surge — whether from a new health hazard, a pandemic, or a structural shift in global hygiene standards — will come. And when it does, the players who survived the downcycle, optimised their cost base, and kept their balance sheets clean will be the ones who ride it hardest.

The Lesson:

Cyclical industries are not about timing the top. They're about surviving the bottom. The companies that cut fat, invested in efficiency, and didn't blow up their balance sheets during the boom are the ones still standing.

Top Glove and Hartalega are still standing. That's not nothing.

---

Not investment advice. DYODD. I'm just sharing my observations from watching this sector go through its full cycle.
2 weeks · translate
This is a cancerous tumour, should be removed from Bursa before killing more innocent investors
2 weeks · translate
Three concrete actions management should prioritize, ranked by potential impact:

1. Execute the Fleet Renewal with Precision: The market doesn't reward potential; it rewards execution. The new 60T AHTS vessels, scheduled for delivery in 2028, need to be delivered on time and on budget. These modern, more fuel-efficient vessels could significantly improve operational margins and contract rates, directly boosting future earnings.‌‌

2. Demonstrate Consistent Profitability: Investors need proof that the company can make money in any market, not just during oil price spikes. A key metric to watch is the Return on Equity (ROE). A sustained improvement in ROE, driven by higher vessel utilization and better cost management, would give investors a reason to buy, making the stock's low P/B ratio (0.4x) truly attractive.

3. Establish a Clear Capital Return Policy: A dividend is often a more credible signal of confidence than a buyback . The recent share capital reduction has cleared the path for future distributions . If Perdana can start paying a consistent, sustainable dividend, it would attract a whole new class of income-focused investors.‌

Not a financial advice , DYODD
3 weeks · translate
6 Analysts, 6 Opinions. What's Really Going On?

• CGS International: ADD (TP RM1.14) — "accelerated growth"
• Maybank: SELL (TP RM0.73) — "recovery priced in"
• Kenanga: MARKET PERFORM (TP RM0.82) — "oil price cuts both ways"
• CIMB: REDUCE (TP RM0.70) — "outlook remains challenging"
• HLIB: SELL (TP RM0.73) — "peak ASP behind us"
• UOB Kay Hian: HOLD (TP RM0.85) — "challenges persist"

Lessons:

Six professionals, same facts, wildly different conclusions. This isn't a bug — it's the market's way of saying "we don't know."

Buffett and Munger don't read analyst reports for a reason: they're often backward-looking, constrained by career risk and can't replace primary research.

This is what you to do instead:
• Read the actual 4QFY26 financials and concall transcript
• Ask yourself: "Do I believe the ASP spike is durable? Can they pass through costs? Will China compete harder?"
• Your answer — not the analysts' — should drive your decision

Not financial advice. DYODD.
3 weeks · translate
Consensus analyst expectations project Top Glove’s Profit After Tax (PAT) to land in the range of RM95 million to RM100 million. If above will create momentary interest but if below will negate the interest for past few days. Let see how it unfolds. May the market forces be with everyone.
3 weeks · translate
OS Capital Sdn Bhd is a licensed community credit provider and a wholly-owned subsidiary of OSK Holdings Berhad, a major Malaysian conglomerate.

🏢 About OS Capital

· Core Business: As a subsidiary of OSK Holdings, it specialises in providing non-bank financial solutions, such as financing and lending, to businesses and individuals.
· Key Personnel: The company recently posted a job opening for a "Manager, Debt Recovery & Remedial Management," indicating it operates with significant funds and credit resources.

🔗 Parent Company Context

· OSK Holdings: This is a diversified group with core businesses spanning Property, Financial Services, Industries, and Hospitality across Malaysia and Australia.
· Financial Strength: The Group manages total assets exceeding RM12 billion and shareholders' funds of RM8.8 billion, indicating strong financial backing for its subsidiaries.

In summary, the entry of OS Capital into FPI appears to be a strategic move by a larger Malaysian financial group. It is distinct from the other major shareholders like Formosa Prosonic Holdings or Denka Company (who are in the manufacturing sector).
1 month · translate
英科医疗科技股份有限公司
INTCO Medical Technology Co., Ltd.
全球英科,健康全球 Global INTCO Global Health

英科医疗大中华区产品价格调整通知函

尊敬的合作伙伴:

您好!

衷心感谢您长期以来对英科医疗的信任与支持。

受全球原油及化工大宗商品价格大幅上涨影响,行业整体成本大幅提升,一次性丁腈手套核心原材料急剧上涨,且呈持续攀升趋势。我司生产成本显著上升,经营压力持续加大。面对上述情况,我司已全力通过内控管控消化成本压力。但面对核心原材料成本骤增,为保障产品品质、稳定供货能力,维护双方长期稳定合作,经公司审慎研究决定:

自2026年9月9日起,根据产品规格和克重差异,英科医疗一次性丁腈手套产品价格上涨15-40元/箱不等;具体事项请与我司业务团队沟通咨询,我们将第一时间为您解答。

再次感谢您的理解与鼎力支持!英科医疗将一如既往坚守品质与服务,与您携手共进,稳健同行,共创长远发展。

顺颂商祺!

英科医疗科技股份有限公司
2026年9月8日

(右下角为公司地址及联系方式)

---

底部社交媒体配文:
#英科丁腈手套涨价 #英科涨价通知 #英科丁腈手套备货 受原材料成本上涨影响,英科一次性手套产品价...
1 month · translate
INTCO Medical Technology Co., Ltd.
Global INTCO Global Health

Notice on Product Price Adjustment in INTCO Medical's Greater China Region

Dear Partners,

Greetings!

We sincerely thank you for your long-term trust in and support for INTCO Medical.

Affected by the sharp rise in global crude oil and bulk chemical prices, the overall cost of the industry has increased significantly. The core raw material for disposable nitrile gloves has soared and continues to show an upward trend. Our production costs have risen significantly, and the pressure on operating performance continues to increase. In the face of this situation, our company has made every effort to absorb cost pressures through internal controls. However, given the surge in core raw material costs, in order to ensure product quality, stabilize supply capacity, and maintain long-term stable cooperation, our company has decided after careful study:

Starting from September 9, 2026, based on differences in product specifications and gram weights, the prices of INTCO Medical's disposable nitrile gloves will increase by 15-40 RMB/carton. For specific matters, please consult with our business team, and we will answer your questions as soon as possible.

Once again, thank you for your understanding and strong support! INTCO Medical will, as always, adhere to quality and service, and work hand in hand with you to move forward steadily and develop together.

Wishing you prosperous business!

INTCO Medical Technology Co., Ltd.
September 8, 2026
1 month · translate
The capital reduction is officially 100% complete.

The "Effective Date" has passed

· Date of completion: 14 August 2026 (the date it was lodged with the Registrar of Companies).
· The proposed reduction is now legally finalized and cannot be reversed.

The New Share Capital Structure

As stated in the announcement, the company's issued share capital is now reduced to RM282,286,743.36.

· Total ordinary shares: 2,227,909,141 (unchanged from before—your share count is the same).
· Total RCPS: 14,191,007 (down slightly from Q1 2026 as more RCPS converted).
· Important note: Since the share count didn't change, the share capital reduction was purely a book-keeping entry.

What happens to the Retained Earnings now?

· Before reduction (Q1 2026): Accumulated Losses of -RM205.6 million.
· Capital Reduction amount: The company wiped out RM600 million from the Share Capital account.
· New Retained Earnings: RM600m (wiped) – RM205.6m (previous losses) = approx. +RM394.4 million.

Perdana's balance sheet now officially has positive retained earnings for the first time in years.

What this means for you?

· Your shares: Exactly the same number. No dilution.
· No cash for you today: This is purely a balance sheet clean-up.
· The real payoff: Future dividends are now legally possible. Because they wiped out the negative retained earnings, Perdana can now pay dividends from future profits.
· Caveat: They can pay dividends, but they are still losing money operationally (Q1 2026 net loss of RM12.1M). Dividends won't happen until they return to consistent profitability.

Bottom line: The "financial engineering" is now fully done. The ball is now entirely on management to turn their operational cash flow into actual net profits with their new vessels.
2 months · translate
这篇来自银河国际证券(CGS International)的分析报告,是一个非常值得注意的“行业拐点信号”。

简单来说:看好一直在赌的“中国厂商撑不住”这件事,可能正在发生。

让我把这篇新闻核心信息拆解成三个点,并告诉这对Hartalega 持仓意味着什么:

1. 核心信号:中国厂商开始“踩刹车”和“退出”了

这篇报道给出了过去两年手套股最大的利空——“中国倾销”正在发生实质性的变化:

· 中国扩产踩刹车: 过去几年一直在疯狂扩建产能的中国手套厂,终于放慢了脚步。
· 旧产能退出市场: 那些成本高、效率低、在价格战中亏损的老旧工厂,开始关停或倒闭。
· 数据验证: 报告指出中国手套厂2025年的销售量仅增长1.8%,但EBIT(息税前盈利)却暴跌39%。这说明,中国企业是在“牺牲利润来保销量”,这种模式是不可持续的。

2. 对 Hartalega 的直接利好:市场份额正在回流

分析明确指出:“马来西亚手套业在全球销量的市场份额已有回升迹象。”

· 中国厂商为了保持销量不得不亏本卖货,但亏损无法永远持续。当他们被迫退出市场时,谁接住了订单?答案是拥有最低成本结构和最高质量认证的马来西亚厂商——Hartalega 正是其中最大的受益者。

3. 为什么这个消息对持仓者很重要?(与 RHB 报告的对比)

· 之前的担忧(RHB报告): 认为中国厂商会继续价格战,压制 ASP,导致 Hartalega 的未来黯淡。
· 现在的转折(银河国际): 证明中国厂商已经精疲力尽,难以再发动持久的价格战。

这正是我选择 Hartalega 作为长期投资的核心逻辑:这是“一场钱包比谁厚的战壕战”。Hartalega 有 RM 11 亿净现金,能扛住几年亏损;但许多中国竞争对手没有,他们正在流血出局。

结论

1. 持Hartalega 不仅仅是“赌战争红利”。 这篇文章证明,即使没有伊朗战争,由于中国产能的收缩,马来西亚手套行业的基本面也正在发生结构性的改善。
2. 短期 Q2 利润下滑是有预期的,不要被吓到。 7月到9月(Q2)ASP 的回落和成本的错配,确实会让下一份财报很难看。这已经被市场完全计入了股价。
3. 既然中国厂商在退场,那么明年起,一旦全球需求恢复,ASP 将不再受制于中国低价倾销,而是会稳定在一个更健康的水平(可能回到 US$20-22 甚至更高)。

总结: 这篇新闻是手套行业“供给侧改革”的一个重要信号。持Hartalega 不是持有在了一个即将被中国击败的行业,而是持有在一个即将完成“大清洗”的幸存者身上。耐心是你的盟友。
2 months · translate
Load more